Active Colony Stimulating Factor 3, Granulocyte (GCSF) Mus musculus (Mouse) Active protein

CSF3; G-CSF; Granulocyte Colony Stimulating Factor; Pluripoietin; Filgrastim; Lenograstim

Add to Cart Distributors
Overview
Properties
  • Buffer Formulation20mM Tris, 150mM NaCl, pH8.0, containing 1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose and Proclin300.
  • Traits Freeze-dried powder, Purity > 90%
  • Isoelectric Pointn/a
Share your citation Upload your experimental result Review Leave a message
Loading...

Share a new citation as an author

Upload your experimental result

Review

Please attach serial No. on instruction manual

Contact us

Please fill in the blank.

Name*
Organization
Address
E-mail address*
Telephone
Inquiry*
Verification code* CheckCode
  • Active Colony Stimulating Factor 3, Granulocyte (GCSF) Packages (Simulation)
  • Active Colony Stimulating Factor 3, Granulocyte (GCSF) Packages (Simulation)
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Activity test

Colony Stimulating Factor 3, Granulocyte (GCSF) is a cytokine primarily produced by monocytes, macrophages, and endothelial cells. It plays a crucial role in regulating the proliferation, differentiation, and survival of neutrophils, a type of white blood cell essential for combating bacterial infections. G-CSF is widely used clinically to accelerate neutrophil recovery in patients undergoing chemotherapy or hematopoietic stem cell transplantation. It binds specifically to the Colony Stimulating Factor Receptor, Granulocyte (GCSFR), a member of the cytokine receptor family expressed on myeloid progenitor cells and mature neutrophils, thereby initiating intracellular signaling pathways that promote cell growth and function.To detect the activity of recombinant GCSF a functional ELISA assay was performed to evaluate the interaction between recombinant mouse GCSF and recombinant mouse GCSFR.Briefly, GCSF was diluted serially in PBS with 0.01% BSA (pH 7.4). Duplicate samples of 100 μl were then transferred to GCSFR-coated microtiter wells and incubated for 1h at 37℃. Wells were washed with PBST and incubated for 1h with anti-GCSF pAb, then aspirated and washed 3 times. After incubation with HRP labelled secondary antibody for 1h at 37℃, wells were aspirated and washed 5 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37℃. Finally, add 50 µL stop solution to the wells and read at 450/630nm immediately. The binding activity of recombinant mouse GCSF and recombinant mouse GCSFR was shown in Figure 1, the EC50 for this effect is 0.296µg/mL.

Usage

Reconstitute in 20mM Tris, 150mM NaCl (PH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

Storage

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

Stability

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Citations

  • The Transcriptional Foundations of Sp110-mediated Macrophage (RAW264. 7) Resistance to Mycobacterium tuberculosis H37RaPubmed:26912204
  • Low-density neutrophils in severe fever with thrombocytopenia syndrome (SFTS) display decreased function to phagocytose SFTS virus and enhanced capacity to synthesize cytokinesISSN:1936-2625/IJCEP0045334
  • Ginsenoside Rg3 improves cyclophosphamide-induced immunocompetence in Balb/c micePubmed: 30974284
  • Oridonin alleviates kanamycin-related hearing loss by inhibiting NLRP3/caspase-1/gasdermin D-induced inflammasome activation and hair cell pyroptosisPubmed:35749835

Recommend products